{"id":51193,"date":"2022-11-23T15:02:34","date_gmt":"2022-11-23T14:02:34","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/"},"modified":"2022-11-23T15:02:34","modified_gmt":"2022-11-23T14:02:34","slug":"feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/","title":{"rendered":"Feinstein Institutes awarded $3.6M from New York State for spinal cord injury research"},"content":{"rendered":"
\n

MANHASSET, N.Y.–(BUSINESS WIRE)–The spinal cord plays a vital role in the human body \u2013 it acts as the information highway sending signals to and from our brain, helping to control our movements and process sensations. When someone suffers a spinal cord injury (SCI) it can lead to paralysis, sometimes in all four limbs. To better understand what happens to the brain and body after a SCI and to develop new methods of treatment using bioelectronic medicine<\/a> to regain movement and sensation, researchers at The <\/a>Feinstein Institutes for Medical Research<\/a> have been awarded a five-year, $3.6 million grant from the New York State Department of Health to study spinal cord stimulation and novel brain implant technology.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe research study, led by Chad Bouton<\/a>, vice president of advanced engineering and professor at the Institute of Bioelectronic Medicine at the Feinstein Institutes,<\/a> along with co-principal investigators Ashesh Mehta, MD, PhD<\/a>, from the Feinstein Institutes, and Susan Harkema, PhD, at the University of Louisville, will assess if cervical stimulation \u2013 alone and in combination with brain implants \u2013 could promote lasting movement.\n<\/p>\n

\n\u201cLosing movement in all four limbs makes tasks like getting out of bed, brushing your teeth, and getting dressed impossible. There is a drastic deterioration in quality of life and currently there is no cure for permanent paralysis,\u201d said Prof. Bouton, the study\u2019s principal investigator. \u201cWith the state\u2019s generous support, we have the potential to study new bioelectronic medicine solutions that could restore movement for those living with spinal cord injuries.\u201d\n<\/p>\n

\nPrevious research<\/a> from Prof. Bouton, Dr. Santosh Chandrasekaran, a researcher with the Feinstein Institutes, and their colleagues shows that cervical stimulation applied at the base of the neck can lead to improved recovery after injury. The new study will analyze the combination of cervical stimulation and brain-computer interface (BCI) technology that involves the placement of multiple small \u201cchips\u201d (tiny micro-electrodes) in the brain. Researchers will enroll 12 participants who will receive over-the-skin spinal cord stimulation for 12 months, and two participants will begin with over-the-skin stimulation for several months, followed by six months of BCI-driven over-the-skin spinal cord stimulation to facilitate further recovery.\n<\/p>\n

\nThrough activity-based and BCI-assisted training sessions, individuals with SCI will conduct tasks while receiving cervical stimulation. The goal is to observe the stimulation\u2019s effect on the brain\u2019s activity patterns and arm and hand movements to restore long-term control of the muscles.\n<\/p>\n

\n\u201cNew York State support of this project comes at a critical time as advances in bioelectronic medicine continue to make progress towards enhancing mobility in patients with spinal cord injury,\u201d said Kevin J. Tracey, MD<\/a>, president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research. \u201cThis also supports an important and productive collaboration between Feinstein Institutes\u2019 Chad Bouton and his team with the University of Louisville team led by Susan Harkema, PhD.\u201d\n<\/p>\n

\nThe Feinstein Institutes is the scientific home of bioelectronic medicine, the scientific field that combines molecular medicine, neuroscience and biomedical engineering to develop innovative therapies using computer chips and devices instead of drugs to treat various diseases and conditions through the stimulation of nerves, including paralysis.\n<\/p>\n

\nAbout the Feinstein Institutes
\n
<\/i><\/b>The Feinstein Institutes for Medical Research<\/i><\/a> is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine \u2013 a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit<\/i> <\/i>http:\/\/feinstein.northwell.edu<\/i><\/a> <\/i>and follow us on<\/i> <\/i>LinkedIn<\/i><\/a>.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nJulianne Mosher Allen
\n
516-880-4824
\n
jmosherallen@northwell.edu<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MANHASSET, N.Y.–(BUSINESS WIRE)–The spinal cord plays a vital role in the human body \u2013 it acts as the information highway sending signals to and from our brain, helping to control our movements and process sensations. When someone suffers a spinal cord injury (SCI) it can lead to paralysis, sometimes in all four limbs. To better … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51193","6":"format-standard","7":"category-industry"},"yoast_head":"\nFeinstein Institutes awarded $3.6M from New York State for spinal cord injury research - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Feinstein Institutes awarded $3.6M from New York State for spinal cord injury research - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MANHASSET, N.Y.–(BUSINESS WIRE)–The spinal cord plays a vital role in the human body \u2013 it acts as the information highway sending signals to and from our brain, helping to control our movements and process sensations. When someone suffers a spinal cord injury (SCI) it can lead to paralysis, sometimes in all four limbs. To better ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-23T14:02:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221123005090\/en\/1645611\/21\/Bouton_News.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Feinstein Institutes awarded $3.6M from New York State for spinal cord injury research\",\"datePublished\":\"2022-11-23T14:02:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\\\/\"},\"wordCount\":660,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221123005090\\\/en\\\/1645611\\\/21\\\/Bouton_News.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\\\/\",\"name\":\"Feinstein Institutes awarded $3.6M from New York State for spinal cord injury research - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221123005090\\\/en\\\/1645611\\\/21\\\/Bouton_News.jpg\",\"datePublished\":\"2022-11-23T14:02:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221123005090\\\/en\\\/1645611\\\/21\\\/Bouton_News.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221123005090\\\/en\\\/1645611\\\/21\\\/Bouton_News.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Feinstein Institutes awarded $3.6M from New York State for spinal cord injury research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Feinstein Institutes awarded $3.6M from New York State for spinal cord injury research - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/","og_locale":"en_US","og_type":"article","og_title":"Feinstein Institutes awarded $3.6M from New York State for spinal cord injury research - Pharma Trend","og_description":"MANHASSET, N.Y.–(BUSINESS WIRE)–The spinal cord plays a vital role in the human body \u2013 it acts as the information highway sending signals to and from our brain, helping to control our movements and process sensations. When someone suffers a spinal cord injury (SCI) it can lead to paralysis, sometimes in all four limbs. To better ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-23T14:02:34+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221123005090\/en\/1645611\/21\/Bouton_News.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Feinstein Institutes awarded $3.6M from New York State for spinal cord injury research","datePublished":"2022-11-23T14:02:34+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/"},"wordCount":660,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221123005090\/en\/1645611\/21\/Bouton_News.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/","url":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/","name":"Feinstein Institutes awarded $3.6M from New York State for spinal cord injury research - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221123005090\/en\/1645611\/21\/Bouton_News.jpg","datePublished":"2022-11-23T14:02:34+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221123005090\/en\/1645611\/21\/Bouton_News.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221123005090\/en\/1645611\/21\/Bouton_News.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-awarded-3-6m-from-new-york-state-for-spinal-cord-injury-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Feinstein Institutes awarded $3.6M from New York State for spinal cord injury research"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51193"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51193\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}